-

Mexico Xikin Project Panorama, 2020 - Oil & Gas Upstream Analysis - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Mexico Xikin Project Panorama - Oil and Gas Upstream Analysis Report" report has been added to ResearchAndMarkets.com's offering.

Summary

Mexico Xikin Project Panorama, the publisher's latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential.

Scope

  • Overview of the asset based on an analysis of the economic indicators
  • Key financial indicators including Net Present Value and Internal Rate of Return
  • Review of factors affecting the economic outcome of the field including development overview, geology, challenges, reserves and production with qualitative perspective on of the overall assets life with the publisher's analysis on the asset's future outlook
  • Detailed production profile for the asset, giving annual output rates for each commodity produced
  • Cash flow statements from our economic analysis of the asset including capital expenditures, operating expenditures and tax liability
  • Individual valuations for equity holders
  • Sensitivity analysis for asset value considering a range of factors

Reasons to buy

  • Understand the economic and non-economic factors that affect production of an asset
  • Benefit from an asset valuation derived from detailed research and modeling by our analysts
  • Basic view of various scenarios and its effect on the asset for risk or strategy planning
  • Utilize the quantitative and qualitative evaluation to ascertain trends within the region to inform decision making
  • Identify economic trends of an asset to determine investment requirements

Key Topics Covered:

  • Field Details
  • Asset Update
  • Asset Outlook
  • Economic Analysis
  • Development Overview
  • Reserves and Production
  • Geology
  • Economic Assumptions
  • Appendix
  • Contact Us
  • Disclaimer

For more information about this report visit https://www.researchandmarkets.com/r/o5mjw

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

South Africa Manufacturing Industry Trends Report 2025: Focus on Food and Beverages, Metal, Petrochemical and Automotive Industries - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Manufacturing Trends in South Africa 2025" report has been added to ResearchAndMarkets.com's offering. This report on trends in the manufacturing sector in South Africa, which is concentrated in the food and beverages, metal, petrochemical and automotive industries, provides information on the size and state of the manufacturing sector including contribution to GDP, performance, employment, production, profitability, trade, tariffs and fixed investment. Investing i...

United States Semaglutide Market Forecast and Company Analysis Report 2025-2033 Featuring Novo Nordisk, Eli Lilly and Co, AstraZeneca, Biocon, Johnson and Johnson, Pfizer, AbbVie, and Sanofi - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "United States Semaglutide Market Report by Product, Application, Distribution Channel, States and Company Analysis, 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Semaglutide Market is expected to expand from US$ 8.17 Billion in 2024 to US$ 17.29 Billion in 2033 at a Compound Annual Growth Rate (CAGR) of 8.68% during 2025-2033 The growth is fueled by rising awareness regarding obesity control, increasing incidence of diabetes,...

GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global Forecast to 2033: Growing Shift of Weekly Injectables Toward Orals and Multi-Agonists - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, Tirzepatide), Type (Patented, Biosimilars), Format (Single Dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. The GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% The report will help market leaders/new...
Back to Newsroom